Canine Infectious Respiratory Disease Complex (Cirdc)

Question 1 / 12

🏆 Rank #-- ▾

Score 0/100

1. Which elements of sheltering animals may enhance transmission of CIRDC if not appropriately managed?

Overcrowding and cleaning procedures

Co-housing and/or co-mingling, including playgroups

Inadequate isolation

Common areas and surfaces

All of the above

About This Quiz

Canine Infectious Respiratory Disease Complex (Cirdc) - Quiz

Infectious respiratory disease can be a significant challenge affecting the health of dogs in a shelter setting. This presentation, given by Stephanie Janeczko, DVM, MS, DABVP, CAWA, provides an overview of the disease complex, discussing causative agents, diagnosis and treatment. Management and preventive strategies is emphasized. Date: July... see more2014Venue: 2014 ASPCA/Cornell Maddie's® Shelter Medicine Conference see less

2. What first name or nickname would you like us to use?

You may optionally provide this to label your report, leaderboard, or certificate.

2. We hope you have enjoyed the presentation. If you receive a passing score, a Certificate of Attendance in your name will be awarded at the end of this quiz. Please let us know if you have viewed the entire presentation.

I certify that I have viewed the entire presentation.

I did not view the entire presentation.

3. Typical clinical signs of CIRDC include:

Upper airway (i.e., ocular and nasal discharge, coughing +/- terminal retch).

Fever.

Poor body condition.

Difficulty walking.

A and B, otherwise bright, alert and responsive.

A, C and D.

All of the above.

4. Husbandry issues contribute both to the dose of viral and bacterial pathogens and to an animal's susceptibility (e.g., stress, airway irritation).

True

False

5. Recognition of specific clinical signs can be sufficient to distinguish between various causes of Canine Infectious Respiratory Disease Complex (CIRDC).

True

False

6. Which statement about diagnostic testing for CIRDC is true?

Testing of multiple animals makes it difficult to determine the pathogen mix in the population.

Testing should be done for all dogs showing upper respiratory signs.

Testing is done using blood samples.

Testing can be done by all diagnostic testing laboratories.

Positive test results for one or more organisms does not necessarily prove causation of clinical signs.

7. Which statement about canine respiratory coronavirus (CRCoV), Group 2 infection is true?

It is the same as the GI tract coronavirus in dogs.

It is not easily transmitted.

It is limited to infection of respiratory tissues.

It is typically associated with mild upper respiratory symptoms.

8. Most pathogens associated with CIRDC are efficiently transmitted via:

Direct oronasal contact and aerosolized respiratory secretions up to 25 feet.

Direct oronasal contact and aerosolized respiratory secretions up to 50 feet.

Indirect oronasal contact and aerosolized respiratory secretions up to 25 feet.

Indirect oronasal contact and aerosolized respiratory secretions up to 50 feet.

None of the above.

9. Which statement about canine pneumovirus (CnPnV) infection is true?

It was one of the first pathogens identified to be associated with CIRDC.

It has been isolated from dogs at shelters with acute upper respiratory symptoms.

Cytopathic effects seen in cell culture are the same as other known causes of CIRDC.

Its role as a primary pathogen has been well defined.

No additional research is being done on CnPnV.

10. Which statement about canine influenza infection is true?

It is problematic for any dog in high density housing.

Clinical signs are distinct from those caused by other pathogens in the CIRDC.

The incubation period is 2-5 weeks.

Shedding peeks 2-4 weeks post-infection and ends by week 7-10.

Clinically ill dogs shed the lowest levels of virus early.

11. Core vaccines for the prevention of CIRDC (and other diseases) are:

Canine distemper, adenovirus type 1 and 2, canine parvovirus and parainfluenza (DA2PP); Intranasal Bordetella; and Canine influenza virus (CIV).

Canine distemper, adenovirus type 1 and 2, canine parvovirus and parainfluenza (DA2PP); Intranasal Bordetella and Parainfluenza; and Borrelia burgdorferi.